Equity
€716,337 ▼ 3.6%
SCOMED paid out €101,370 in dividends. That is 128% of the 2025 profit.
SCOMED
Lifetime
10 annual accounts with figures on one time axispeak €131,519 (2016)
€96,855▼ 23.9%
peak €116,618 (2024)
€79,260▼ 32.0%
peak €743,448 (2024)
€716,337▼ 3.6%
€147,852▲ 256%
Board2 names since 2015
1 director
Owners
Documentsfilings and deeds
19-05-202673 days before the deadline
2025micro format
Gross margin from €127,242 to €96,855Result from €116,618 to €79,260Dividend €101,370Debts from €41,508 to €147,852
Key points
from the 2025 annual accountsTurnover
≈ €220,000 estimated
The micro format states no turnover.
Liquidity
5.84 was 18.70 in 2024
Short-term debts rose from €41,508 to €147,852.
Filings
10 annual accounts 6 late
The 2024 accounts came latest: 153 days after the end of the period.
At the same address
360 companies
Position in the sector
€716,337
More equity than 88% of companies in human health. Sector median €125,064 · 21,313 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 17,811 companies had the same profile as SCOMED has now. Each dot stands for 45 companies, two years later.
96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 17,811 companies, not a prediction for SCOMED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered office moved from Jette to Uccle
New registered office: Chaussée d'Alsemberg 897, 1180 Uccle · Previous registered office: Rue Valère Broekaert 77, 1090 Jette · General meeting of 13-05-2026 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0628872774
Registered office moved from Molenbeek-Saint-Jean to Brussels
New registered office: rue Valère Broekaert 77 à 1090 BRUXELLES · Previous registered office: rue Alfred Dubois 12 à 1080 MOLENBEEK SAINT - JEAN · Board meeting of 01-07-2015 · Gazette deed
Incorporation
published on 07-05-2015 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| SCOMED Uccle | €864,189 | €96,855 | 82.9% | - |
| Dr. Philip Vulsteke Ypres | €841,374 | €103,162 | 2.2% | - |
| DR. TOON CEYSSENS Woluwe-Saint-Pierre | €742,375 | €113,809 | 4.4% | - |
| Dr. Jan Schrijvers huisarts Brussels | €777,507 | €92,168 | 80.5% | - |
| Dr Pierre Déome Woluwe-Saint-Lambert | €952,526 | €115,961 | 45.6% | - |
| Dr Nele Mortier Kortrijk | €743,914 | €99,706 | 29.2% | - |
| Velghe-Raes Kortrijk | €782,403 | €84,952 | 31.8% | - |
These companies have the same main activity as SCOMED: general medical practice (NACE 86210). They are comparable in size and age: total assets between €742,000 and €953,000, founded between 2011 and 2017.
Official details
Source: KBO- Status
- Active since 24-04-2015Normal situation
- Registered office
- 362 active companies are registered at this address79 started in the 12 months before. Source: KBO register, as of 13 November 2026.
- Activity
- General medical practiceNACE 86210
- Establishment unit
- 2.303.815.5247060 Soignies, since 24-04-2015
- Financial year end
- 31 December
- Peppol
- Reachable since 27-03-2026
Annual accounts 2025
- €864,189▲ 10.1%
- Filing
- Filed on 19-05-2026, 73 days before the end of the filing period
Insights on SCOMED
SCOMED files the micro format. That format states no turnover. The gross margin fell from €131,519 in 2016 to €96,855 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about SCOMED
- What is the company number of SCOMED?
- The company number of SCOMED is 0628.872.774. The VAT number is the same number with BE in front: BE 0628.872.774.
- Where is SCOMED based?
- The registered office is at Alsembergsesteenweg 897, 1180 Uccle.Company details
- What does SCOMED do?
- According to the KBO register, the main activity is general medical practice (NACE 86210).
- What is the legal form of SCOMED?
- SCOMED is a private limited company (pre-2019) (BVBA).
- When was SCOMED founded?
- SCOMED was founded on 24-04-2015.
- Is SCOMED still active?
- Yes, SCOMED is an active enterprise in the KBO register.
- What is the turnover of SCOMED?
- The turnover in financial year 2025 is ≈ €220,000. This figure is estimated from the gross margin of €96,855 and 32 comparable companies (NACE 862). It probably lies between €170,000 and €280,000.Financials
- Is SCOMED profitable?
- In financial year 2025, SCOMED made a profit of €79,260.
- Where can I find the annual accounts of SCOMED?
- SCOMED filed 10 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of SCOMED due?
- SCOMED must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.